Interestingly, integrated whole-transcriptome and genomic methylation analyses have identified both Frmd4a and Frmd4b as candidate gene products involved in networks specific to late-onset Alzheimer’s disease [39,40]. Here, FRMD4A is linked to Alzheimer disease.